WEKO3
アイテム
Two years outcomes of treating full-thickness macula hole associated with idiopathic macular telangiectasia type 2 by internal limiting membrane inverted flap technique Case reports
http://hdl.handle.net/10295/00005848
http://hdl.handle.net/10295/00005848a41f13af-42d0-4487-812a-d4bc0c906777
Item type | 学術雑誌論文 / Journal Article(1) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
公開日 | 2021-11-25 | |||||||||
タイトル | ||||||||||
タイトル | Two years outcomes of treating full-thickness macula hole associated with idiopathic macular telangiectasia type 2 by internal limiting membrane inverted flap technique Case reports | |||||||||
言語 | en | |||||||||
言語 | ||||||||||
言語 | eng | |||||||||
主題 | ||||||||||
主題Scheme | Other | |||||||||
主題 | fluorescein angiography | |||||||||
主題 | ||||||||||
主題Scheme | Other | |||||||||
主題 | full-thickness macular hole | |||||||||
主題 | ||||||||||
主題Scheme | Other | |||||||||
主題 | idiopathic macular telangiectasia type 2 | |||||||||
主題 | ||||||||||
主題Scheme | Other | |||||||||
主題 | internal limiting membrane with inverted flap | |||||||||
主題 | ||||||||||
主題Scheme | Other | |||||||||
主題 | optical coherence tomography | |||||||||
主題 | ||||||||||
主題Scheme | Other | |||||||||
主題 | pars plana vitrectomy | |||||||||
資源タイプ | ||||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||
資源タイプ | journal article | |||||||||
アクセス権 | ||||||||||
アクセス権 | open access | |||||||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||||
作成者 |
Nishiyama, Shungo
× Nishiyama, Shungo
× Iwase, Takeshi
|
|||||||||
内容記述 | ||||||||||
内容記述タイプ | Abstract | |||||||||
内容記述 | Abstract Rational: Macular telangiectasia (MacTel) is an uncommon ocular disorder that can lead to legal blindness. MacTel type 2 is characterized by a bilateral loss of macular transparency, the presence of white crystals on the retina, aberrant blood vessel growth, and neurodegeneration of the macula. Full-thickness macular holes (FTMHs) are a prominent cause of vision reduction in MacTel type 2, and the standard care for an FTMH is pars plana vitrectomy (PPV) to restore the FTMH and best-corrected visual acuity (BCVA). However, surgical outcomes in previous reports were not good, with a lack of closure or a reopening of the FTMH, compared with those with an idiopathic FTMH. Thus, this study aimed to determine the surgical outcomes of PPV with the inverted ILM flap technique for the treatment of FTMHs with a 2-year postoperative follow-up in three patients with MacTel type 2. Patient concerns: This study involved 3 patients who had been diagnosed with MacTel type 2 at a local eye clinic and who was subsequently referred to our department for a more detailed examination. Diagnoses: Three patients were diagnosed with MacTel type 2 using dilated ophthalmoscopy, fluorescein angiography, and optical coherence tomography (OCT) in both eyes. A FTMH was developed and visual acuity decreased during follow-up period in all of the patients. Interventions: Each patient underwent PPV in 1 eye using the inverted ILM-flap technique, gas tamponade, and prone positioning. Outcomes: The FTMH was successfully closed in the 3 cases after the surgery. OCT showed that the FTMH remained closed at the last follow-up examination in 2 patients and vision improved to 20/20 and 20/25. In the other patient, the hole was closed temporarily after surgery, but was reopened at 6 months. The vision had improved to 20/60 until the hole was reopened, and it was 20/100 at the final follow-up examination. Lessons: Although only 3 patients were examined, the inverted ILM-flap technique may be an effective and safe method to close an FTMH in patients with MacTel type 2. However, the surgery cannot prevent the reopening of the hole when the retinal atrophy progresses. Abbreviations: BBG = brilliant blue G, BCVA = best-corrected visual acuity, CNV = choroidal neovascularization, FTMH = fullthickness macular hole, ILM = internal limiting membrane, MacTel = macular telangiectasia, OCT = optical coherence tomography, PPV = pars plana vitrectomy. | |||||||||
言語 | en | |||||||||
出版タイプ | ||||||||||
出版タイプ | VoR | |||||||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||
書誌情報 |
en : Medicine 巻 100, 号 36, 発行日 2021 |
|||||||||
収録物識別子 | ||||||||||
収録物識別子タイプ | ISSN | |||||||||
収録物識別子 | 1536-5964 | |||||||||
出版者 | ||||||||||
出版者 | Wolters Kluwer Health, Inc. | |||||||||
関連情報 | ||||||||||
識別子タイプ | DOI | |||||||||
関連識別子 | https://doi.org/10.1097/MD.0000000000027078 | |||||||||
関連名称 | Version of record (open access) | |||||||||
権利情報 | ||||||||||
権利情報 | Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |